SCHEMBL2002860

SCHEMBL2002860

CCCCCC(O)(c1ccc(Cl)cc1)c1ccc(Cl)cc1

nearest known ligand 0.64

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
BCL2 P10415 2/20 0.64
SMN1; SMN2 Q16637 2/20 0.60
POLB P06746 1/20 0.60
L3MBTL1 Q9Y468 1/20 0.60
NPSR1 Q6W5P4 3/20 0.49
MEN1 O00255 4/20 0.47
KMT2A Q03164 4/20 0.47
SCN5A Q14524 3/20 0.47
SCN9A Q15858 3/20 0.47
SIGMAR1 Q99720 1/20 0.45
LMNA P02545 1/20 0.44
HTT P42858 1/20 0.44
ALDH1A1 P00352 1/20 0.43
TSHR P16473 1/20 0.42
MAPK1 P28482 1/20 0.42
HIF1A Q16665 1/20 0.42
HDAC3 O15379 1/20 0.40
HDAC1 Q13547 1/20 0.40
HDAC2 Q92769 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2009309 0.80 BCL2 (0.62) BCL2SMN1; SMN2POLBL3MBTL1NPSR1
SCHEMBL12316587 0.79 SCN5A (0.75) BCL2SMN1; SMN2POLBL3MBTL1NPSR1
SCHEMBL22175881 0.78 CNR2 (0.56) SMN1; SMN2POLBL3MBTL1MEN1KMT2A
SCHEMBL11413546 0.78 SIGMAR1 (0.64) BCL2SMN1; SMN2SCN5ASCN9ASIGMAR1
SCHEMBL28270229 0.78 SIGMAR1 (0.64) BCL2SMN1; SMN2SCN5ASCN9ASIGMAR1
SCHEMBL5395161 0.78 SIGMAR1 (0.64) BCL2SMN1; SMN2SCN5ASCN9ASIGMAR1
SCHEMBL17613471 0.78 SMN1; SMN2 (0.45) BCL2SMN1; SMN2POLBL3MBTL1NPSR1
SCHEMBL12267924 0.77 SCN5A (0.65) BCL2SMN1; SMN2SCN5ASCN9ASIGMAR1
SCHEMBL13131547 0.77 NPSR1 (0.57) BCL2SMN1; SMN2POLBL3MBTL1NPSR1
SCHEMBL25039175 0.77 SMN1; SMN2 (0.44) BCL2SMN1; SMN2POLBL3MBTL1MEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7960526-B2 Colorimetric-oxycarbonyl protecting groups for use in organic syntheses BERRY AND ASSOCIATES, INC. (US) 2011-06-14 US disclosed
US-7960526-B2 Colorimetric-oxycarbonyl protecting groups for use in organic syntheses BERRY AND ASSOCIATES, INC. (US) 2011-06-14 US disclosed
US-7960526-B2 Colorimetric-oxycarbonyl protecting groups for use in organic syntheses BERRY AND ASSOCIATES, INC. (US) 2011-06-14 US disclosed
WO-2010114762-A1 COLORIMETRIC-OXYCARBONYL PROTECTING GROUPS FOR USE IN ORGANIC SYNTHESES BERRY AND ASSOCIATES, INC. (US) 2010-10-07 WO disclosed
US-20100249393-A1 COLORIMETRIC-OXYCARBONYL PROTECTING GROUPS FOR USE IN ORGANIC SYNTHESES BERRY AND ASSOCIATES, INC. (US) 2010-09-30 US disclosed
US-20100249393-A1 COLORIMETRIC-OXYCARBONYL PROTECTING GROUPS FOR USE IN ORGANIC SYNTHESES BERRY AND ASSOCIATES, INC. (US) 2010-09-30 US disclosed
US-20100249393-A1 COLORIMETRIC-OXYCARBONYL PROTECTING GROUPS FOR USE IN ORGANIC SYNTHESES BERRY AND ASSOCIATES, INC. (US) 2010-09-30 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100249393-A1 COLORIMETRIC-OXYCARBONYL PROTECTING GROUPS FOR USE IN ORGANIC SYNTHESES RNGTT, OGA, HCCS BCL2 2618/4885SMN1; SMN2 1166/4885POLB 699/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.